Followers | 14 |
Posts | 1919 |
Boards Moderated | 0 |
Alias Born | 04/16/2024 |
Thursday, December 12, 2024 8:01:36 PM
FOUSE and Schenkein too busy delaying trials and engagin the analyst to pump their stock.
Recent AGIO News
- Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio • GlobeNewswire Inc. • 01/13/2025 12:00:00 PM
- FDA Accepts Agios’ Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia • GlobeNewswire Inc. • 01/08/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2025 10:05:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/06/2025 11:36:01 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/03/2025 09:25:33 PM
- Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025 • GlobeNewswire Inc. • 01/03/2025 12:00:00 PM
- European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios’ Mitapivat in Sickle Cell Disease • GlobeNewswire Inc. • 12/18/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2024 09:04:41 PM
- Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat • GlobeNewswire Inc. • 12/08/2024 05:40:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 08:44:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2024 09:14:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/12/2024 09:09:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/12/2024 09:08:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/08/2024 09:17:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/07/2024 09:06:29 PM
- Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition • GlobeNewswire Inc. • 11/05/2024 02:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/31/2024 01:20:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 10:56:28 AM
- Agios Reports Business Highlights and Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 10/31/2024 10:30:00 AM
- Agios Completes Enrollment of Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease • GlobeNewswire Inc. • 10/23/2024 11:00:00 AM
- Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024 • GlobeNewswire Inc. • 10/17/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2024 08:15:29 PM
- Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS) • GlobeNewswire Inc. • 09/11/2024 11:00:00 AM
- Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024 • GlobeNewswire Inc. • 09/05/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:15:37 PM
UC Asset Announces Plan of Secondary Public Offering via Reg A • UCASU • Jan 23, 2025 9:30 AM
Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • ZEFIF • Jan 21, 2025 10:51 AM
North Bay Resources Acquires 70% Interest in the Bishop Gold Mill, Inyo County, California • NBRI • Jan 21, 2025 9:26 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM